| Schedule of Cash Flow, Supplemental Disclosures |
Supplemental cash flow and non-cash information (in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor |
|
|
Predecessor |
|
Year Ended December 31, 2022 |
|
Period from May 18, 2021 through December 31, 2021 |
|
|
Period from January 1, 2021 through May 17, 2021 |
|
Year Ended December 31, 2020 |
| Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
|
|
| Cash paid for reorganization items, net |
$ |
— |
|
|
$ |
85,706 |
|
|
|
$ |
87,199 |
|
|
$ |
24,553 |
|
| Interest payments |
57,685 |
|
|
33,295 |
|
|
|
7,272 |
|
|
84,823 |
|
| Income tax receipts |
— |
|
|
(9,381) |
|
|
|
— |
|
|
— |
|
| Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
| (Increase) decrease in accounts receivable - oil, natural gas, and natural gas liquids sales |
(45,550) |
|
|
(52,143) |
|
|
|
(60,832) |
|
|
1,331 |
|
| (Increase) decrease in accounts receivable - joint interest and other |
(1,095) |
|
|
(5,178) |
|
|
|
(3,005) |
|
|
36,055 |
|
| Increase (decrease) in accounts payable and accrued liabilities |
59,879 |
|
|
(72,912) |
|
|
|
79,193 |
|
|
126,434 |
|
| (Increase) decrease in prepaid expenses |
4,863 |
|
|
13,559 |
|
|
|
135,471 |
|
|
(154,948) |
|
| (Increase) decrease in other assets |
1,330 |
|
|
3,630 |
|
|
|
3,067 |
|
|
(2,087) |
|
| Total changes in operating assets and liabilities |
$ |
19,427 |
|
|
$ |
(113,044) |
|
|
|
$ |
153,894 |
|
|
$ |
6,785 |
|
| Supplemental disclosure of non-cash transactions: |
|
|
|
|
|
|
|
|
| Capitalized stock-based compensation |
$ |
2,948 |
|
|
$ |
1,101 |
|
|
|
$ |
930 |
|
|
$ |
2,860 |
|
| Asset retirement obligation capitalized |
2,169 |
|
|
7,964 |
|
|
|
546 |
|
|
2,358 |
|
| Asset retirement obligation removed due to divestiture |
(7) |
|
|
— |
|
|
|
— |
|
|
(2,213) |
|
| Interest capitalized |
— |
|
|
198 |
|
|
|
— |
|
|
907 |
|
| Pre-petition revolver principal transfer to DIP credit facility |
— |
|
|
— |
|
|
|
— |
|
|
157,500 |
|
| Fair value of contingent consideration asset on date of divestiture |
— |
|
|
— |
|
|
|
— |
|
|
23,090 |
|
| Release of Common Stock held in reserve |
28,220 |
|
|
23,893 |
|
|
|
— |
|
|
— |
|
| Foreign currency translation gain on equity method investments |
— |
|
|
— |
|
|
|
2,570 |
|
|
3,833 |
|
|
| Schedule of Accounts Payable and Accrued Liabilities |
Accounts payable and accrued liabilities consisted of the following at December 31, 2022 and December 31, 2021 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor |
|
December 31, 2022 |
|
December 31, 2021 |
| Accounts payable and other accrued liabilities |
$ |
117,529 |
|
|
$ |
98,821 |
|
| Revenue payable and suspense |
222,721 |
|
|
180,857 |
|
| Accrued contract rejection damages and shares held in reserve |
40,996 |
|
|
69,216 |
|
| Accrued transportation, gathering, processing, and compression |
56,138 |
|
|
45,117 |
|
| Total accounts payable and accrued liabilities |
$ |
437,384 |
|
|
$ |
394,011 |
|
|